TITLE

Emergent BioSolutions Lands $1.25B BioThrax Contract

AUTHOR(S)
Powers, Marie
PUB. DATE
October 2011
SOURCE
BioWorld Today;10/4/2011, Vol. 22 Issue 192, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that U.S. Centers for Disease Control and Prevention has awarded Emergent BioSolutions Inc. worth 1.25 U.S. billion dollars to supply the U.S. government with 44.75 million doses of anthrax vaccine adsorbed, BioThrax for about five years. BioThrax is the only anthrax vaccine that is approved by the Food and Drug Administration (FDA). Deliveries of the BioThrax will start 2011 and will end in September 2016.
ACCESSION #
66423965

 

Related Articles

  • Emergent BioThrax Multiyear Pact Worth up to $404M.  // BioWorld Today;10/2/2008, Vol. 19 Issue 192, p3 

    The article announces that Emergent BioSolutions Inc. has signed a new multiyear contract to supply the U.S. government with 14.5 million doses of BioThrax anthrax vaccine. According to the article, the contract extends the government's commitment to purchase BioThrax through the third quarter...

  • Emergent BioSolutions Receives FDA Approval for BioThrax Administered Intramuscularly in a Three-Dose Primary Series Followed by Booster Doses.  // Biomedical Market Newsletter;5/18/2012, Vol. 21, p1 

    The article informs that the U.S.-based Food and Drug Administration has approved the supplemental Biologics License Application (sBLA) of BioThrax developed by Emergent BioSolutions Inc. It further informs that the vaccine helps in protecting adults against the anthrax disease. It mentions that...

  • Emergent BioSolutions' Investigational Anthrax Vaccine, NuThrax, Granted Fast Track Designation.  // Biomedical Market Newsletter;6/19/2011, p1120 

    The article provides information on NuThrax anthrax vaccine of Emergent BioSolutions Inc., which has received Fast Track Designation from the U.S. Food & Drug Administration (FDA). It states that NuThrax is being assessed in a Phase 1b clinical trial for tolerability, immunogenicity, and safety....

  • CDC Awards Emergent BioSolutions Potential $1.3B for Anthrax Countermeasure.  // TR2: Terror Response Technology Report;10/12/2011, Vol. 7 Issue 21, p14 

    The article reports on the contract awarded by the U.S. Centers for Disease Control (CDC) to Emergent BioSolutions for several doses of BioThrax anthrax vaccine.

  • Emergent BioSolutions Receives $44 Million CDC Contract.  // Contract Pharma;Sep2015, Vol. 17 Issue 7, p149 

    The article reports on the $44 million worth of contract given to biopharmaceutical company Emergent BioSolutions Inc. from the U.S. Centers for Disease Control and Prevention (CDC) to supply Vaccinia Immune Globulin (VIGIV) antibodies.

  • Other News To Note.  // BioWorld Today;6/10/2011, Vol. 22 Issue 112, p8 

    This section offers biotechnology industry news briefs as of June 10, 2011. NASDAQ granted an additional 180-day grace period to Arrowhead Research Corp. to comply with the stock exchange's one dollar minimum bid requirement. The U.S. Food and Drug Administration (FDA) granted fast-track status...

  • Manufacturers argue against mandatory training for opioid prescribers. Traynor, Kate // American Journal of Health-System Pharmacy;1/15/2010, Vol. 67 Issue 2, p96 

    The article reports that manufacturers of opioid medications have requested U.S. Food and Drug Administration (FDA) to adopt a careful method for changing prescription practices as the agency develops a risk evaluation and mitigation strategy (REMS) for some of these medications. According to...

  • Cessation shelf is smokin'.  // Drug Store News;1/10/2011, Vol. 33 Issue 1, p46 

    The article reports on the programs initiated by the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration.

  • Handwashing Versus Alcohol-Based Gels---FDA Information.  // Journal of Environmental Health;Sep2003, Vol. 66 Issue 2, p40 

    The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are working together to control the transmission of pathogens that can result in foodborne illnesses. Transmission of pathogenic bacteria, viruses, and parasites from raw food or from ill workers...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics